Given that ccRCC is characterized by pronounced glycolytic and lipid anabolic features, we hypothesize that PUMA can facilitate metabolism reprogramming and malignant progression in ccRCC. The gene discussed is BBC3; the disease is nonpapillary renal cell carcinoma.